Chemocentryx Profitability Analysis

CCXI -  USA Stock  

USD 15.78  0.20  1.25%

For Chemocentryx profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chemocentryx to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chemocentryx utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chemocentryx's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chemocentryx over time as well as its relative position and ranking within its peers. Continue to Trending Equities.

Search Current Profitability Trends 

 
Refresh
The current Sales per Share is estimated to increase to 1.49, while Price to Sales Ratio is projected to decrease to 56.19. The current Accumulated Other Comprehensive Income is estimated to increase to about 123 K, while Consolidated Income is projected to decrease to (56.8 M).

Chemocentryx Revenues

54.5 MillionShare
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Chemocentryx EBITDA vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Chemocentryx's current stock value. Our valuation model uses many indicators to compare Chemocentryx value to that of its competitors to determine the firm's financial worth.
Chemocentryx is number one stock in return on asset category among related companies. It is number one stock in ebitda category among related companies . . Chemocentryx Earnings Before Interest Taxes and Depreciation Amortization EBITDA are most likely to decrease significantly in the upcoming years. The last year's value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA was reported at (49.95 Million)

Chemocentryx EBITDA vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Chemocentryx 
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
(11.20) %
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Chemocentryx 
EBITDA 
 = 
Revenue 
-  
Basic Expenses 
(61.61 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Chemocentryx EBITDA Comparison

Chemocentryx Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Chemocentryx, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Chemocentryx will eventually generate negative long term returns. The profitability progress is the general direction of Chemocentryx's change in net profit over the period of time. It can combine multiple indicators of Chemocentryx, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2021
Accumulated Other Comprehensive Income114 K123 K
Consolidated Income-55.4 M-56.8 M
Net Income-55.4 M-56.8 M
Net Income Common Stock-55.4 M-56.8 M
Operating Income-55.2 M-56.6 M
Income Tax Expense-65.7 K-70.9 K
Net Income Per Employee-415.1 K-447.8 K
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Chemocentryx. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Chemocentryx position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Chemocentryx's important profitability drivers and their relationship over time.

Chemocentryx Profitability Trends

Chemocentryx profitability trend refers to the progression of profit or loss within a business. An upward trend means that Chemocentryx's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Chemocentryx's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Chemocentryx Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Chemocentryx different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Chemocentryx in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Chemocentryx's future profitability.

Use Chemocentryx in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Trading

Chemocentryx Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Chemocentryx position

In addition to having Chemocentryx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Advertising Thematic Idea Now

Advertising
Advertising Theme
Companies specializing in advertising, marketing and advertising services. Advertising theme has 30 constituents.
View All  Next Launch Advertising
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
To fully project Chemocentryx's future profitability" href="/future-stock-price/CCXI">future profitability, investors should examine all historical financial statements" href="/financial-statements/CCXI">financial statements. These statements provide investors with a comprehensive snapshot of the financial position" href="/financial-statements/CCXI">financial position of Chemocentryx at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements" href="/financial-statements/CCXI">financial statements. These documents include Chemocentryx's income statement, its balance sheet, and the statement of cash flows.
Potential Chemocentryx investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Chemocentryx investors may work on each financial statement separately, they are all related. The changes in Chemocentryx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemocentryx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.